🇺🇸 FDA
Pipeline program

Study of GS-5319 in Adults With Solid Tumors

GS-US-707-7297

Phase 1 other active

Quick answer

Study of GS-5319 in Adults With Solid Tumors for Advanced solid tumors is a Phase 1 program (other) at Gilead Sciences International Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Gilead Sciences International Limited
Indication
Advanced solid tumors
Phase
Phase 1
Modality
other
Status
active

Clinical trials